Merck & Co. Inc. buy Argus
Start price
07.06.24
/
50%
€119.60
Target price
07.06.25
-
Performance (%)
-42.31%
End price
08.06.25
€69.00
Summary
This prediction ended on 08.06.25 with a price of €69.00. Massive losses of -42.31% were the result for the BUY prediction by Argus. Dividends of €2.99 are taken into consideration when calculating the performance. Argus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Merck & Co. Inc. | 5.542% | 5.542% | 59.307% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % |
Comments by Argus for this prediction
In the thread Merck & Co. Inc. diskutieren
Merck & Co., Inc. (NYSE: MRK) was upgraded by analysts at Argus to a "strong-buy" rating.
Ratings data for MRK provided by MarketBeat
In the thread Trading Merck & Co. Inc.
Die von Argus gewählte maximale Laufzeit wurde überschritten